Reports for SANDOZ IRBESARTAN HCT

Brand name

SANDOZ IRBESARTAN HCT

Company Name
SANDOZ CANADA INCORPORATED
Drug Identification Number
02337436
Ingredients
HYDROCHLOROTHIAZIDE
IRBESARTAN
Ingredient Strength
12.5 MG
300 MG
ATC Code
C09DA
C09DA
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Status
MARKETED
Shortage reports
Brand name Packaging Size Status Date Created Date Updated Reports
SANDOZ IRBESARTAN HCT 100 Resolved 2019-03-05 2020-07-20 77655
SANDOZ IRBESARTAN HCT 500 Resolved 2019-04-01 2020-06-22 80194
SANDOZ IRBESARTAN HCT 100FCT BO CA Resolved 2020-09-21 2020-10-27 124609
SANDOZ IRBESARTAN HCT 500FCT BO CA Resolved 2020-09-21 2020-10-27 124612
SANDOZ IRBESARTAN HCT 100FCT Resolved 2023-03-06 2023-03-28 186285
SANDOZ IRBESARTAN HCT 100FCT BO Resolved 2023-08-07 2023-08-15 201264
SANDOZ IRBESARTAN HCT 500FCT Resolved 2023-12-04 2024-01-18 212445
SANDOZ IRBESARTAN HCT 500FCT Resolved 2024-09-16 2024-10-15 237750
SANDOZ IRBESARTAN HCT 100FCT Resolved 2024-10-28 2024-12-11 241400

Showing 1 to 9 of 9

Discontinuation reports
Brand name Packaging Size Status Date Created Date Updated Reports

Showing 1 to 0 of 0